BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 18521011)

  • 1. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
    Fu QL; Li X; Yip HK; Shao Z; Wu W; Mi S; So KF
    Neuroscience; 2009 Aug; 162(2):375-82. PubMed ID: 19422885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo.
    Pernet V; Di Polo A
    Brain; 2006 Apr; 129(Pt 4):1014-26. PubMed ID: 16418178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic nerve and neuroprotection strategies.
    Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
    Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
    Wilson AM; Di Polo A
    Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-derived neurotrophins may influence the survival of adult retinal ganglion cells when local neurotrophic support is disrupted: Implications for glaucoma.
    Murphy JA; Clarke DB
    Med Hypotheses; 2006; 67(5):1208-12. PubMed ID: 16806723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of retinal ganglion cell death in glaucoma.
    Almasieh M; Wilson AM; Morquette B; Cueva Vargas JL; Di Polo A
    Prog Retin Eye Res; 2012 Mar; 31(2):152-81. PubMed ID: 22155051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging medical therapies in the treatment of glaucoma.
    Bagnis A; Papadia M; Scotto R; Traverso CE
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different optic nerve injury sites result in different responses of retinal ganglion cells to brain-derived neurotrophic factor but not neurotrophin-4/5.
    Zhi Y; Lu Q; Zhang CW; Yip HK; So KF; Cui Q
    Brain Res; 2005 Jun; 1047(2):224-32. PubMed ID: 15904902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy and transplantation in CNS repair: the visual system.
    Harvey AR; Hu Y; Leaver SG; Mellough CB; Park K; Verhaagen J; Plant GW; Cui Q
    Prog Retin Eye Res; 2006 Sep; 25(5):449-89. PubMed ID: 16963308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma.
    Zhou X; Li F; Ge J; Sarkisian SR; Tomita H; Zaharia A; Chodosh J; Cao W
    Dev Neurobiol; 2007 Apr; 67(5):603-16. PubMed ID: 17443811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M; Urcola JH; Vecino E
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.